Cyclica launches new multitargeted drug design technology Ligand Design

Cyclica launches new multi-targeted drug design technology Ligand Design

07:05 EDT 23 May 2019 | Pharmaceutical Business Review

This revolutionary platform empowers scientists in the pharmaceutical industry to generate novel drug-like compounds by combining powerful methods for molecule generation, ADMET prediction, and high-throughput ligand-protein interaction prediction.

The post Cyclica launches new multi-targeted drug design technology Ligand Design appeared first on Pharmaceutical Business review.

Original Article: Cyclica launches new multi-targeted drug design technology Ligand Design

More From BioPortfolio on "Cyclica launches new multi-targeted drug design technology Ligand Design"